Company Analysis

BioAge Labs, Inc. (BIOA)

Nasdaq: BIOA · Pharmaceutical Preparations · Emeryville, CA · filing with the SEC since 2024
Grade5.6
◀ Past 4.4● Present 6.6▶ Future 5.4
5 est.

Filings

86 filings since 2017 beside 71 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 21, 2026.

Filings a yearinsider forms included
594157
202420252026

2026 counts to Nov 13, 2026.

SEC letters: 11 in the last 36 months, the newest Sep 25, 2024.
Insider forms 71

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 2, 2026 8-K item 8.01 Other event · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 5, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 12, 2026 8-K item 5.07 Shareholder vote · Current report Jun 10, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 8, 2026 8-K items 2.02, 9.01 Results released · Current report
May 8, 2026 10-Q Quarterly report Mar 31, 2026
Apr 27, 2026 SCHEDULE 13G Large holder notice
Apr 21, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 21, 2026 DEFA14A Extra proxy material
Apr 21, 2026 DEF 14A Proxy statement Jun 10, 2026
Mar 24, 2026 S-3ASR Shelf registration
Mar 24, 2026 S-8 Employee stock plan registration
Mar 24, 2026 10-K Annual report Dec 31, 2025
Mar 24, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 22, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Jan 21, 2026
Jan 22, 2026 424B5 Shelf offering
Jan 20, 2026 424B5 Shelf offering
Jan 20, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jan 12, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Dec 4, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 6, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 5, 2025 S-3/A Shelf registration, amended
Nov 5, 2025 S-3/A Shelf registration, amended
Oct 2, 2025 S-3 Shelf registration
Oct 2, 2025 S-3 Shelf registration
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2025 SCHEDULE 13G Large holder notice
Aug 6, 2025 10-Q Quarterly report Jun 30, 2025
Aug 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 9, 2025 8-K item 5.07 Shareholder vote · Current report Jun 5, 2025
Jun 4, 2025 8-K item 8.01 Other event · Current report
40 of 86 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BIOA · research, not advice